| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | XL413 (BMS-863233) hydrochloride is an orally active and selective CDC7 inhibitor (IC50=3.4 nM). XL413 hydrochloride exhibits favorable pharmacokinetic profiles and effectively suppresses tumor growth in rodent models. XL413 hydrochloride serves as a valuable tool in cancer research [1]. | ||
| 细胞研究 | |||||
|---|---|---|---|---|---|
| 细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
| Caco2 cells | Function assay | Induction of apoptosis in human Caco2 cells assessed as increase in caspase 3/7 activity, EC50=2.288 μM | 22560567 | ||
| human Caco2 cells | Function assay | 4 h | Inhibition of CDC7 in human Caco2 cells assessed as inhibition of MCM2 phosphorylation at Ser53 after 4 hrs, IC50=0.14 μM | 22560567 | |
| human Caco2 cells | Proliferation assay | Antiproliferative activity against human Caco2 cells assessed as inhibition of anchorage-independent growth in soft agar, IC50=0.715 μM | 22560567 | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
3.07mL 0.61mL 0.31mL |
15.33mL 3.07mL 1.53mL |
30.66mL 6.13mL 3.07mL |
| 参考文献 |
|---|